Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Group CBT and SSRIs in OCD
NCT02739061Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Jun 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of sertraline and fluvoxamine in obsessive compulsive disorder (OCD) (3 arms), sponsored by Shanghai Mental Health Center. Primary endpoint: Yale-Brown Obsessive Compulsive Scale at 36 weeks. Started Jun 2014; status: completed.
02
Drugs
sertralinefluvoxamine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT02739061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739061.